The Venture Codex Logo

The Venture Codex

Biohaven Pharmaceutical Holding Company

215 Church Street, New Haven, CT, 06510, United States

Overview

Clinical-stage biopharmaceutical company targeting neurological diseases.

Founded

2013

Deals ยท 12mo

0

Stage focus

Series A

Geographic focus

Slovenia

Sector focus

Biotechnology
Health Care
Health Diagnostics
Neuroscience
...

Investment portfolio

1rounds
NAMEDATESIZE
Artizan
Mar 2021Led
$11 MSeries A
Artizan
Mar 2021Led
$11 MSeries A
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Biohaven Pharmaceutical Holding Company: 1 funding rounds are recorded in the selected participation categories.All available history.
Biohaven Pharmaceutical Holding Company: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10

Monthly Deal Activity

Biohaven Pharmaceutical Holding Company: 1 deals are recorded across 68 months.All available history.
Biohaven Pharmaceutical Holding Company: 1 deals are recorded across 68 months. All available history
MonthDeals
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Biohaven Pharmaceutical Holding Company: Marketing & Advertising is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Biohaven Pharmaceutical Holding Company: Marketing & Advertising is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Marketing & Advertising1

Deal Size Distribution

Biohaven Pharmaceutical Holding Company: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Biohaven Pharmaceutical Holding Company: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Biohaven Pharmaceutical Holding Company: Europe has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Biohaven Pharmaceutical Holding Company: Europe has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Europe1
Biohaven Pharmaceutical Holding Company: 4 co-investors are shown, with Connecticut Innovations sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Biohaven Pharmaceutical Holding Company: 4 co-investors are shown, with Connecticut Innovations sharing 1 recorded deals. All available history
Co-investorShared deals
Connecticut Innovations1
Elm Street Ventures1
Hatteras Venture Partners1
Osage University Partners1

Investment Strategy

Biohaven Pharmaceutical Holding Company: Led accounts for 100% and participating for 0% of round participation.All available history.
Biohaven Pharmaceutical Holding Company: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Biohaven Pharmaceutical Holding Company: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Biohaven Pharmaceutical Holding Company: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

James Engelhart

Chief Financial Officer

Matt Buten

Chief Financial Officer

Michael E. Bozik

President, Biohaven Labs

Nick Kozauer

SVP, Clinical Development & Regulatory Strategy

Rob Berman

Co-Founder and Strategic Advisor

Steven Dworetzky

SVP, Kv7 Strategy and Development

Vlad Coric

Chief Executive Officer

William "BJ" Jones

Chief Commercial Officer, Migraine and Common Diseases